Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Lecigon vs Duodopa in Advanced Parkinson's Disease
NCT02448914Phase 1Completed
- Sponsor
- Lobsor Pharmaceuticals
- Start
- May 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lecigon in Parkinson's disease (PD) (2 arms), sponsored by Lobsor Pharmaceuticals. Primary endpoint: Dose Adjusted Area Under the Curve (AUC) (0-14h) for Levodopa. Started May 2015; status: completed.
02
Drugs
Lecigon
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02448914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448914.